← Back to Search

Audit and Feedback (A&F) for Infections

N/A
Waitlist Available
Led By Noah M Ivers
Research Sponsored by Women's College Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test the effect of audit and feedback (A&F) on reducing unnecessary antibiotic prescribing in Ontario family physicians not already receiving A&F.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antibiotic prescribing rate
Secondary outcome measures
Antibiotic drug costs
Antibiotics prescribed for viral infections
Proportion Antibiotic Rx with Prolonged Duration
+2 more

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group: No Harms Emphasis - Simple ComparatorExperimental Treatment1 Intervention
Physicians in this group will receive a personalized antibiotic prescribing feedback letter which contains a simple comparator to represent a target or benchmark for antibiotic prescribing. For the simple comparator we will rank the antibiotic prescribing outcomes for all Ontario family physicians and use the lowest quartile as the benchmark. The letter will also include information on lack of benefit of unnecessary use of antibiotics. Physicians will also receive a paper-copy viral prescription pad and will receive the intervention letter again 1-month post initial dissemination.
Group II: Intervention Group: No Harms Emphasis - Complex ComparatorExperimental Treatment1 Intervention
Physicians in this group will receive a personalized antibiotic prescribing feedback letter which contains a complex (adjusted) comparator to represent a target or benchmark for antibiotic prescribing. For the complex comparator, recipients will be compared only to top-performing 'like-peers' - the group of physicians with similar complexity and numbers of patients. We will adjust the prescribing indicators for patient sex, number of patients >85 years, rurality, continuity of care score, proportion of emergency room practice, proportion nursing home practice, neighborhood income quintile of patients, and rates of common patient comorbidities. The letter will also include information on lack of benefit of unnecessary use of antibiotics. Physicians will also receive a paper-copy viral prescription pad and will receive the intervention letter again 1-month later.
Group III: Intervention Group: Harms Emphasis - Simple ComparatorExperimental Treatment1 Intervention
Physicians in this group will receive a personalized antibiotic prescribing feedback letter which contains a simple comparator to represent a target or benchmark for antibiotic prescribing. For the simple comparator, we will rank the antibiotic prescribing outcomes for all Ontario family physicians and use the lowest quartile as the benchmark. The letter will also include information on both lack of benefit and potential harms caused by unnecessary use of antibiotics. Physicians will also receive a paper-copy viral prescription pad and will receive the intervention letter again 1-month post initial dissemination.
Group IV: Intervention Group: Harms Emphasis - Complex ComparatorExperimental Treatment1 Intervention
Physicians in this group will receive a personalized antibiotic prescribing feedback letter which contains a complex (adjusted) comparator to represent a target or benchmark for antibiotic prescribing. For the complex comparator, recipients will be compared only to top-performing 'like-peers' - the group of physicians with similar complexity and numbers of patients. We will adjust the prescribing indicators for patient sex, number of patients >85 years, rurality, continuity of care score, proportion of emergency room practice, proportion nursing home practice, neighborhood income quintile of patients, and rates of common patient comorbidities. The letter will also include information on both lack of benefit and potential harms caused by unnecessary use of antibiotics. Physicians will also receive a paper-copy viral prescription pad and will receive the intervention letter again 1-month later.
Group V: Control GroupActive Control1 Intervention
Participants in this group will not receive a personalized antibiotic prescribing feedback letter and they will not receive a viral prescription pad.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Audit and Feedback (A&F)
2022
N/A
~5110

Find a Location

Who is running the clinical trial?

Women's College HospitalLead Sponsor
100 Previous Clinical Trials
33,696 Total Patients Enrolled
Ontario Agency for Health Protection and PromotionOTHER_GOV
9 Previous Clinical Trials
18,086 Total Patients Enrolled
College of Family Physicians of CanadaOTHER
7 Previous Clinical Trials
4,711 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for participation in this clinical research?

"According to the information on clinicaltrials.gov, this research is not currently seeking participants. It was initially posted in December 2022 and last updated at that time as well. Although no further candidates are being recruited, there are 39 other medical trials that remain active for enlistment."

Answered by AI
Recent research and studies
Implementation ScienceJournal
Optimizing Responsiveness to Feedback About Antibiotic Prescribing in Primary Care: Protocol for Two Interrelated Randomized Implementation Trials with Embedded Process Evaluations
Shuldiner, Jennifer, Kevin L. Schwartz, Bradley J. Langford, Noah M. Ivers, Monica Taljaard, Jeremy M. Grimshaw, Meagan Lacroix, et al.. 2022. “Optimizing Responsiveness to Feedback About Antibiotic Prescribing in Primary Care: Protocol for Two Interrelated Randomized Implementation Trials with Embedded Process Evaluations”. Implementation Science. Springer Science and Business Media LLC. doi:10.1186/s13012-022-01194-8.
clinicaltrials.govStudy
Do Fair Comparisons or Harms Data Increase Responsiveness to Feedback About Antibiotic Prescribing: 2x2 Factorial Trial
Noah Ivers 2022. "Do Fair Comparisons or Harms Data Increase Responsiveness to Feedback About Antibiotic Prescribing: 2x2 Factorial Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04594200.
~1571 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top